Product NDC: | 16729-231 |
Proprietary Name: | Docetaxel |
Non Proprietary Name: | Docetaxel |
Active Ingredient(s): | 20 mg/mL & nbsp; Docetaxel |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 16729-231 |
Labeler Name: | Accord Healthcare Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA201195 |
Marketing Category: | NDA |
Start Marketing Date: | 20120701 |
Package NDC: | 16729-231-65 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (16729-231-65) > 8 mL in 1 VIAL, SINGLE-USE |
NDC Code | 16729-231-65 |
Proprietary Name | Docetaxel |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (16729-231-65) > 8 mL in 1 VIAL, SINGLE-USE |
Product NDC | 16729-231 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Docetaxel |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120701 |
Marketing Category Name | NDA |
Labeler Name | Accord Healthcare Inc. |
Substance Name | DOCETAXEL |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |